“Adverse Clinical Outcomes Associated With Short Stature At Dialysis Initiation: A Report Of The North American Pediatric Renal Transplant Cooperative Study.”. Pediatrics 109 (5). Pediatrics: 909-13. doi:10.1542/peds.109.5.909.
. 2002. “Long-Term Use Of Recombinant Human Growth Hormone In Pediatric Allograft Recipients: A Report Of The Naprtcs Transplant Registry.”. Pediatr Nephrol 20 (3). Pediatr Nephrol: 404-8. doi:10.1007/s00467-004-1688-5.
. 2005. “Pediatric Transplantation Of The Kidney, Liver And Heart: Summary Report.”. Pediatr Transplant 8 (1). Pediatr Transplant: 75-86. doi:10.1111/j.1399-3046.2004.2s050.x.
. 2004. “Recombinant Growth Hormone Use Pretransplant And Risk For Post-Transplant Lymphoproliferative Disease--A Report Of The Naprtcs.”. Pediatr Transplant 12 (6). Pediatr Transplant: 689-95. doi:10.1111/j.1399-3046.2007.00881.x.
. 2008. “Recombinant Human Growth Hormone Post-Renal Transplantation In Children: A Randomized Controlled Study Of The Naprtcs.”. Kidney Int 62 (2). Kidney Int: 688-96. doi:10.1046/j.1523-1755.2002.00489.x.
. 2002. “The Role Of Apd In The Management Of Pediatric Patients: A Report Of The North American Pediatric Renal Transplant Cooperative Study.”. Semin Dial 15 (6). Semin Dial: 427-9. doi:10.1046/j.1525-139x.2002.00105.x.
. 2002. “Tacrolimus Vs. Cyclosporine A As Primary Immunosuppression In Pediatric Renal Transplantation: A Naprtcs Study.”. Pediatr Transplant 7 (3). Pediatr Transplant: 217-22. doi:10.1034/j.1399-3046.2003.00079.x.
. 2003. “What Have 20 Years Of Data From The North American Pediatric Renal Transplant Cooperative Study Taught Us About Growth Following Renal Transplantation In Infants, Children, And Adolescents With End-Stage Renal Disease?”. Pediatr Nephrol 25 (4). Pediatr Nephrol: 739-46. doi:10.1007/s00467-009-1387-3.
. 2010.